Nice pop on ELTK. Strong backlog for 2022 sounds positive and I like the balance sheet & low float. But the Q4 bottom line excluding the tax benefit was pretty anemic. Would have only been a few pennies per share. So seems fairly valued in the $4's. Will check the CC transcript later to see if anything of note on there.